Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity

A number of drugs and herbal compounds have been documented to cause hepatoxicity. Schisandrin B (Sch B) is an active dibenzocyclooctadiene isolated from Schisandrae fructus, with a wide array of pharmacological activities. However, the potential hepatotoxicity of Sch B is a major safety concern, and the underlying mechanism for Sch B-induced liver toxic effects is not fully elucidated. In the present study, we aimed to investigate the liver toxic effects and the molecular mechanisms of Sch B in mouse liver and macrophage cells. The results have shown that Sch B exhibits potent grow inhibitory, proapoptotic, and proautophagic effects in AML-12 and RAW 264.7 cells. Sch B markedly arrested cells in G1 phase in both cell lines, accompanied by the down-regulation of cyclin dependent kinase 2 (CDK2) and cyclin D1 and up-regulation of p27 Kip1 and checkpoint kinase 1. Furthermore, Sch B markedly increased the apoptosis of AML-12 and RAW 264.7 cells with a decrease in the expression of B-cell lymphoma-extra-large and (Bcl-xl) B-cell lymphoma 2 (Bcl-2), but an increase in the expression of B-cell lymphoma 2-associated X protein (Bax). Sch B promoted the cleavage of caspase 3 and poly-adenosine diphosphate-ribose polymerase (PARP) in both cell lines. Additionally, Sch B significantly induced autophagy of AML-12 and RAW 264.7 cells. Sch B inhibited the activation of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway, as indicated by their altered phosphorylation, contributing to the proautophagic effect of Sch B. Taken together, our findings show that the inducing effects of Sch B on cell cycle arrest, apoptosis, and autophagy may contribute to its liver toxic effects, which might provide a clue for the investigation of the molecular toxic targets and underlying mechanisms for Sch B-induced hepatotoxicity in herbal consumers. More studies are warranted to fully delineate the underlying mechanisms, efficacy, and safety of Sch B for clinical use.

[1]  Ayol Samuels,et al.  Initiation , 1996, Medical Humanities.

[2]  B. Ji,et al.  Hepatoprotective effect of Schisandra chinensis (Turcz.) Baill. lignans and its formula with Rubus idaeus on chronic alcohol-induced liver injury in mice. , 2014, Food & function.

[3]  H. Barnhart,et al.  Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network , 2014, Hepatology.

[4]  Shufeng Zhou,et al.  Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice , 2014, Drug design, development and therapy.

[5]  W. Lu,et al.  Schisandrin B Induces Apoptosis and Cell Cycle Arrest of Gallbladder Cancer Cells , 2014, Molecules.

[6]  R. Young,et al.  D-cyclins repress apoptosis in hematopoietic cells by controlling death receptor Fas and its ligand FasL. , 2014, Developmental cell.

[7]  W. Duan,et al.  Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. , 2014, Cancer letters.

[8]  P. Codogno.  Shining light on autophagy , 2014, Nature Reviews Molecular Cell Biology.

[9]  C. Peng,et al.  Schisandra chinensis Peptidoglycan-Assisted Transmembrane Transport of Lignans Uniquely Altered the Pharmacokinetic and Pharmacodynamic Mechanisms in Human HepG2 Cell Model , 2014, PloS one.

[10]  Baolin Wang,et al.  Causes and Outcomes of Acute Liver Failure in China , 2013, PloS one.

[11]  H. Zhang,et al.  Suppression of Lysosome Function Induces Autophagy via a Feedback Down-regulation of MTOR Complex 1 (MTORC1) Activity* , 2013, The Journal of Biological Chemistry.

[12]  S. Pan,et al.  Novel mouse model of combined hyperlipidemia associated with steatosis and liver injury by a single-dose intragastric administration of schisandrin B/cholesterol/bile salts mixture. , 2013, Journal of pharmacological sciences.

[13]  K. Hunt,et al.  Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner. , 2013, Carcinogenesis.

[14]  K. Guan,et al.  Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy , 2013, Autophagy.

[15]  J. Skotheim,et al.  Control of cell cycle transcription during G1 and S phases , 2013, Nature Reviews Molecular Cell Biology.

[16]  Li Yang,et al.  Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21 789 patients , 2013, European journal of gastroenterology & hepatology.

[17]  P. Boya,et al.  Emerging regulation and functions of autophagy , 2013, Nature Cell Biology.

[18]  M. Schwab,et al.  Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. , 2013, Pharmacology & therapeutics.

[19]  J. Dunnick,et al.  The Toxicity and Pathology of Selected Dietary Herbal Medicines , 2013, Toxicologic pathology.

[20]  R. Teschke,et al.  Herbal hepatotoxicity: a tabular compilation of reported cases , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[21]  Dong Joon Kim,et al.  Drug-induced liver injury: present and future , 2012, Clinical and molecular hepatology.

[22]  D. Rockey,et al.  Drug-induced liver injury , 2012, Current opinion in gastroenterology.

[23]  Angelo A. Izzo,et al.  Interactions Between Herbal Medicines and Prescribed Drugs , 2012, Drugs.

[24]  Zhaohui J. Cai,et al.  Pretreatment data is highly predictive of liver chemistry signals in clinical trials , 2012, Drug design, development and therapy.

[25]  L. Shang,et al.  AMPK and mTOR coordinate the regulation of Ulk1 and mammalian autophagy initiation , 2011, Autophagy.

[26]  T. Roger,et al.  Adiponectin and Heme Oxygenase-1 Suppress TLR4/MyD88-Independent Signaling in Rat Kupffer Cells and in Mice after Chronic Ethanol Exposure , 2010, The Journal of Immunology.

[27]  M. Carrara,et al.  Evaluation of cytotoxic activity of Schisandra chinensis lignans. , 2010, Planta medica.

[28]  Chang Hwa Jung,et al.  mTOR regulation of autophagy , 2010, FEBS letters.

[29]  Michael P Holt,et al.  Drug-induced liver injury. , 2010, Handbook of experimental pharmacology.

[30]  D. Klionsky,et al.  Regulation mechanisms and signaling pathways of autophagy. , 2009, Annual review of genetics.

[31]  D. Sabatini,et al.  mTOR signaling at a glance , 2009, Journal of Cell Science.

[32]  D. Benbrook,et al.  Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. , 2009, Cancer research.

[33]  Zheng Shen,et al.  Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[34]  M. Yaffe,et al.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. , 2009, Current opinion in cell biology.

[35]  Stephen L. Leib,et al.  Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. , 2009, Journal of hepatology.

[36]  Vuong Tran,et al.  Intrinsic negative cell cycle regulation provided by PIP box- and Cul4Cdt2-mediated destruction of E2f1 during S phase. , 2008, Developmental cell.

[37]  Pier Paolo Pandolfi,et al.  The PTEN–PI3K pathway: of feedbacks and cross-talks , 2008, Oncogene.

[38]  Roger B. Davis,et al.  Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. , 2008, JAMA.

[39]  S. Bent,et al.  Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation , 2008, Journal of General Internal Medicine.

[40]  Seon-Yong Jeong,et al.  The role of mitochondria in apoptosis. , 2008, BMB reports.

[41]  N. Mizushima,et al.  Autophagy: process and function. , 2007, Genes & development.

[42]  Shufeng Zhou,et al.  Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. , 2007, Current drug metabolism.

[43]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[44]  J. Uetrecht,et al.  Idiosyncratic drug reactions: current understanding. , 2007, Annual review of pharmacology and toxicology.

[45]  M. Madariaga.  Drug-related hepatotoxicity. , 2006, The New England journal of medicine.

[46]  S. Pan,et al.  A novel experimental model of acute hypertriglyceridemia induced by schisandrin B. , 2006, European journal of pharmacology.

[47]  V. Thakur,et al.  Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[48]  Paul B Watkins,et al.  Drug‐induced liver injury: Summary of a single topic clinical research conference , 2006, Hepatology.

[49]  Xun Hu,et al.  Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. , 2006, Biochemical pharmacology.

[50]  L. Larue,et al.  Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression , 2005, Nature.

[51]  Jiri Bartek,et al.  The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair , 2005, Nature Cell Biology.

[52]  Terry S Peters,et al.  Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials? , 2005, Toxicologic pathology.

[53]  D. Schuppan,et al.  Herbal hepatotoxicity. , 2005, Journal of hepatology.

[54]  Xiaodong Wang,et al.  Cytochrome C-mediated apoptosis. , 2003, Annual review of biochemistry.

[55]  N. Kaplowitz,et al.  Drug-Induced Liver Injury , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[57]  O. Coqueret,et al.  New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? , 2003, Trends in cell biology.

[58]  William M. Lee,et al.  Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States , 2002, Annals of Internal Medicine.

[59]  N. Kaplowitz,et al.  Immune-mediated drug-induced liver disease. , 2002, Clinics in liver disease.

[60]  M. Gómez-Lechón,et al.  The Use of Cultured Hepatocytes to Investigate the Metabolism of Drugs and Mechanisms of Drug Hepatotoxicity , 2001, Alternatives to laboratory animals : ATLA.

[61]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[62]  M. Zhu,et al.  Improvement of phase I drug metabolism with Schisandra chinensis against CCl4 hepatotoxicity in a rat model. , 2000, Planta medica.

[63]  N. Walworth,et al.  The G2-phase DNA-damage checkpoint. , 2000, Trends in cell biology.

[64]  K. Ko,et al.  Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity. , 1995, Planta medica.

[65]  J. Massagué,et al.  Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 , 1995, Nature.